Given the challenges they faced in the initial attempt, I'm curious what others think about the likelihood of success this time around.
Would be great to hear from anyone with reimbursement experience or who’s been tracking EIQ’s regulatory path.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $132.3M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 20.0¢ | $134.4K | 661.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 37400 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 7271 | 1 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| EIQ (ASX) Chart |